Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PRABOTULINUMTOXINA-XVFS for Off label use: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where PRABOTULINUMTOXINA-XVFS was used for Off label use.

Most Reported Side Effects for PRABOTULINUMTOXINA-XVFS

Side Effect Reports % Deaths Hosp.
Drug ineffective 1,332 41.0% 0 2
Off label use 1,088 33.5% 1 5
Therapeutic product effect decreased 714 22.0% 0 0
Drug effect less than expected 354 10.9% 0 0
Headache 153 4.7% 0 6
Injection site pain 99 3.1% 0 0
Patient dissatisfaction with treatment 90 2.8% 0 0
Injection site swelling 89 2.7% 0 0
Inappropriate schedule of product administration 72 2.2% 0 0
Injection site erythema 62 1.9% 0 0
Eyelid ptosis 61 1.9% 0 0
Product preparation issue 56 1.7% 0 0
Injection site pruritus 45 1.4% 0 0
Product storage error 39 1.2% 0 0
Dizziness 33 1.0% 0 3

Other Indications for PRABOTULINUMTOXINA-XVFS

Product used for unknown indication (2,750) Skin wrinkling (1,045) Product use in unapproved indication (152) Face lift (8) Skin cosmetic procedure (5)

Other Drugs Used for Off label use

LENALIDOMIDE (5,767) ECULIZUMAB (3,550) CERTOLIZUMAB PEGOL (2,256) ABOBOTULINUMTOXINA (2,170) LEVETIRACETAM (2,161) APREMILAST (1,995) PROPRANOLOL (1,576) CETIRIZINE (1,416) HUMAN IMMUNOGLOBULIN G (1,129) THALIDOMIDE (1,033)

Related Pages

PRABOTULINUMTOXINA-XVFS Full Profile All Off label use Drugs PRABOTULINUMTOXINA-XVFS Demographics PRABOTULINUMTOXINA-XVFS Timeline